Replies to post #25159 on Endonovo Therapeutics Inc (ENDV)

[sello]

Adding to the O/S does not equate to being sold into the float.

The unrestricted shares have increased approx 9.5 million since September. That is consistent with Eagles daily limit.

Per the agreement with Eagle, there can be no other convertible note holder for one year, until April 7th 2018. Unless the note is redeemed there is no other note holder.

If Eagle increases financing, which they have for the acquisition of RGN, they are still bound by the daily limit for the combined notes though further shares may have been duly assigned, placed in restricted status, until officially issued for conversion, as with the original.